Skip to main content

Human FBXW7/Cdc4 Antibody

R&D Systems, part of Bio-Techne | Catalog # MAB7776

Catalog #
Availability
Size / Price
Qty
Loading...
MAB7776
MAB7776-SP

Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human, Mouse

Applications

Validated:

Western Blot

Cited:

Western Blot, Immunocytochemistry

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG2B Clone # 800201

Product Specifications

Immunogen

E. coli-derived recombinant human FBXW7/Cdc4
Lys377-Lys707
Accession # Q969H0

Specificity

Detects human FBXW7/Cdc4 in direct ELISAs.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2B

Scientific Data Images for Human FBXW7/Cdc4 Antibody

Detection of Human FBXW7/Cdc4 antibody by Western Blot.

Detection of Human FBXW7/Cdc4 by Western Blot.

Western blot shows lysates of Jurkat human acute T cell leukemia cell line. PVDF membrane was probed with 2 µg/mL of Mouse Anti-Human FBXW7/Cdc4 Monoclonal Antibody (Catalog # MAB7776) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). A specific band was detected for FBXW7/Cdc4 at approximately 110 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Detection of brqg9ujed6vbcpgfvygo.jpg by Immunohistochemistry

Detection of brqg9ujed6vbcpgfvygo.jpg by Immunohistochemistry

FBXW7 protects against NASH.a Analysis of hepatic FBXW7 expression in patients across the severity stages of NAFLD progression. n = 50 for NAFL; n = 87 for NASH_F0-2; n = 68 for NASH_F3-4. bFBXW7 mRNA levels in fibrotic liver biopsies from patients with NAFLD. n = 137 for Fibrosis stage 0-2; n = 68 for Fibrosis stage 3-4. Relative mRNA levels of NASH progression signature genes (c), inflammation and fibrogenesis genes (d) in Flox (control) and Fbxw7-null livers, n = 5. e Immunoblots and quantification of proteins related to NASH progression in livers and serum from Flox and Fbxw7L−/− littermates. Each lane represents one mouse, n = 3. f Overall immune contents of control and Fbxw7-null livers, reflected by the absolute immune fraction scores, n = 3. g Stacked bar chart illustrating cell distributions of control and Fbxw7-null livers, n = 3. CAFs Cancer-associated fibroblasts, na non-applicable. GSEA of SAMac-defining signature (h) and hepatic stellate cell signature (i). Array genes were ordered from the highest in Fbxw7-null livers (left) to the highest in control livers (right). Locations of genes in each signature are indicated by the vertical black bars. NES normalized enrichment score. Representative images and quantification of Aif1 (j) and alphaSMA (k) immunohistochemistry (IHC) staining, n = 4. Scale bars, 50 μm. l mRNA expression of ER stress and apoptotic genes in control and Fbxw7-null livers, n = 5. m Immunoblots and quantification of proteins related to ER stress and apoptosis. Each lane represents one mouse, n = 3. Data are presented as means ± SEM (a–f, j–m). *p < 0.05, unpaired two-tailed Student’s t test (a–g, j–m). Source data are provided as a Source Data file. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37914694), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of chnbnm42rnebvmhsgzk7.jpg by Western Blot

Detection of chnbnm42rnebvmhsgzk7.jpg by Western Blot

Metabolic stress aggravates NASH in the absence of Fbxw7.a Heatmap showing mRNA fold changes of NASH-related genes in the fed, fasted and keto diet nutritional regimens, assessed by RT-qPCR, n = 5-6 (see Source data file for specific sample numbers). b Representative images of H&E and Masson’s trichrome (MTC) stained liver tissue sections from Flox and Fbxw7L−/− mice under different nutritional regimens. Arrowhead, fibrotic area (blue). Images are representative of n = 3 mice per group. Immunoblots and quantification of the indicated proteins from Flox and Fbxw7L−/− mice upon fasting (c) or post a 20-day keto diet (d). Each lane represents one mouse, n = 3. e HepG2 cells stably expressing empty vector or FBXW7 were treated with 500 nM Thapsigargin (Tg) or DMSO for 24 h followed by immunoblot examination. Immunoblots are from one experiment representative of 3 independent experiments with similar results. f Overlap of liver-enriched secreted factors with hepatic DEGs (p < 0.05, |FC|>1.30) induced by Fbxw7 deficiency, by fasting, or by a keto diet. g Ranking of the secreted factors identified in Fig. 7f by the sum of absolute mRNA fold changes of the four transcriptome datasets. h, i Hepatic mRNA expression of Apoa4, Apcs and Igfbp1 from Flox and Fbxw7L−/− mice upon fasting (h, n = 5) or post a 20-day keto diet (i, n = 6 for Flox and n = 5 for Fbxw7L−/− mice). Immunoblots and quantification of serum and liver levels of the hepatic secreted factors from Flox and Fbxw7L−/− mice upon fasting (j) or post a 20-day keto diet (k). Each lane represents one mouse, n = 3. Data are represented as means ± SEM (c, d, h–k). *p < 0.05, unpaired two-tailed Student’s t test (a, c, d, h–k). Source data are provided as a Source Data file including Fig. 7a p-values. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37914694), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human FBXW7/Cdc4 Antibody

Application
Recommended Usage

Western Blot

2 µg/mL
Sample: Jurkat human acute T cell leukemia cell line

Reviewed Applications

Read 3 reviews rated 4 using MAB7776 in the following applications:

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Reconstitution

Sterile PBS to a final concentration of 0.5 mg/mL. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: FBXW7/Cdc4

F‑box/WD repeat-containing protein 7 (FBXW7), also known as SEL10, CDC4, and AGO, is an approxiimately 110 kDa protein that functions as a substrate recognition component in SCF E3 ubiquitin-protein ligase complexes. FBXW7-containing complexes also contain CUL1, RBX1, and SKP1 and are responsible for the targeting of multiple proteins involved in cell cycle activation. It plays an important role during embryonic development, in the maintenance of neural, oligodendrocyte, and hematopoietic progenitor cells, and in hepatocyte and adipocyte differentiation. FBXW7 is downregulated or mutated in a variety of cancers.  FBXW7 contains one F‑box domain (aa 278-324) and seven tandem WD repeats (aa 378-659). Alternative splicing generates additional isoforms of human FBXW7 that have deletions and/or substitutions of the N-terminal 167 amino acids. Within aa 377-707, human FBXW7 shares 99.7% and 88% aa sequence identity with mouse and rat FBXW7, respectively.

Long Name

F-box and WD Repeat Domain Containing 7

Alternate Names

AGO, Archipelago Homolog, Cdc4, FBW6, Fbw7, FBX30, FBXO30, FBXW6, SCF(Fbw7), SEL10

Entrez Gene IDs

55294 (Human); 50754 (Mouse)

Gene Symbol

FBXW7

UniProt

Additional FBXW7/Cdc4 Products

Product Documents for Human FBXW7/Cdc4 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human FBXW7/Cdc4 Antibody

For research use only

Loading...
Loading...
Loading...
Loading...
Loading...